Birdwatch Note
2024-03-31 04:27:37 UTC - MISINFORMED_OR_POTENTIALLY_MISLEADING
ワクチンが癌のリスクになる事を示すデータは米国立がん研究所に把握されていません↓ https://www.cancer.gov/about-cancer/coronavirus/covid-19-vaccines-people-with-cancer# その上で、ステージⅣで見つかる症例が異常発生しているという投稿者の主張↓ですが https://twitter.com/teteatete2021/status/1708944207736676772 https://twitter.com/teteatete2021/status/1623823354556973056 年間がん登録数の登録時の進行期の統計を見ると(↓127P https://ganjoho.jp/public/qa_links/report/hosp_c/pdf/2022_report.pdf 2020年は検診が著減し7種のがんでいずれもⅣ期での登録割合が増えていますが、いずれも21,22年は20年より低くなりコロナ禍前に戻る方向であり投稿者の主張のような現象は客観的事実として確認できません。 全体の登録数も検診の減少の為が主でしょうがコロナ前の増加ペースから予測される値より明らかに減ったままです(下記15P https://ganjoho.jp/public/qa_links/report/hosp_c/pdf/2022_report.pdf
Written by F4D2E4CA66E08B99BDDE8328BBF4C2313B853B3595C8AC38600E463328C72D9D
Participant Details
Original Tweet
Tweet embedding is no longer reliably available, due to the platform's instability (in terms of both technology and policy). If the Tweet still exists, you can view it here: https://twitter.com/foo_bar/status/1774237548795318605
Please note, though, that you may need to have your own Twitter account to access that page. I am currently exploring options for archiving Tweet data in a post-API context.
All Information
- ID - 1774292440960438590
- noteId - 1774292440960438590
- participantId -
- noteAuthorParticipantId - F4D2E4CA66E08B99BDDE8328BBF4C2313B853B3595C8AC38600E463328C72D9D Participant Details
- createdAtMillis - 1711859257340
- tweetId - 1774237548795318605
- classification - MISINFORMED_OR_POTENTIALLY_MISLEADING
- believable -
- harmful -
- validationDifficulty -
- misleadingOther - 0
- misleadingFactualError - 1
- misleadingManipulatedMedia - 1
- misleadingOutdatedInformation - 0
- misleadingMissingImportantContext - 1
- misleadingUnverifiedClaimAsFact - 1
- misleadingSatire - 0
- notMisleadingOther - 0
- notMisleadingFactuallyCorrect - 0
- notMisleadingOutdatedButNotWhenWritten - 0
- notMisleadingClearlySatire - 0
- notMisleadingPersonalOpinion - 0
- trustworthySources - 1
- summary
- ワクチンが癌のリスクになる事を示すデータは米国立がん研究所に把握されていません↓ https://www.cancer.gov/about-cancer/coronavirus/covid-19-vaccines-people-with-cancer# その上で、ステージⅣで見つかる症例が異常発生しているという投稿者の主張↓ですが https://twitter.com/teteatete2021/status/1708944207736676772 https://twitter.com/teteatete2021/status/1623823354556973056 年間がん登録数の登録時の進行期の統計を見ると(↓127P https://ganjoho.jp/public/qa_links/report/hosp_c/pdf/2022_report.pdf 2020年は検診が著減し7種のがんでいずれもⅣ期での登録割合が増えていますが、いずれも21,22年は20年より低くなりコロナ禍前に戻る方向であり投稿者の主張のような現象は客観的事実として確認できません。 全体の登録数も検診の減少の為が主でしょうがコロナ前の増加ペースから予測される値より明らかに減ったままです(下記15P https://ganjoho.jp/public/qa_links/report/hosp_c/pdf/2022_report.pdf
Note Status History
| createdAt | timestampMillisOfFirstNonNMRStatus | firstNonNMRStatus | timestampMillisOfCurrentStatus | currentStatus | timestampMillisOfLatestNonNMRStatus | mostRecentNonNMRStatus | participantId |
| 2024-03-31 04:27:37 UTC (1711859257340) |
2024-03-31 10:33:17 UTC (1711881197535) |
CURRENTLY_RATED_HELPFUL | 2024-04-01 03:14:14 UTC (1711941254008) |
CURRENTLY_RATED_HELPFUL | 2024-03-31 10:33:17 UTC (1711881197535) |
CURRENTLY_RATED_HELPFUL |
Note Ratings
| rated at | rated by | |
| 2024-03-31 21:08:46 -0500 | Rating Details | |
| 2024-03-31 19:42:04 -0500 | Rating Details | |
| 2024-03-31 19:29:38 -0500 | Rating Details | |
| 2024-03-31 19:13:08 -0500 | Rating Details | |
| 2024-03-31 19:09:00 -0500 | Rating Details | |
| 2024-03-31 16:48:34 -0500 | Rating Details | |
| 2024-03-31 15:14:58 -0500 | Rating Details | |
| 2024-03-31 15:03:33 -0500 | Rating Details | |
| 2024-03-31 12:57:51 -0500 | Rating Details | |
| 2024-03-31 12:26:15 -0500 | Rating Details | |
| 2024-03-31 12:07:01 -0500 | Rating Details | |
| 2024-03-31 09:49:12 -0500 | Rating Details | |
| 2024-03-31 09:16:59 -0500 | Rating Details | |
| 2024-03-31 08:55:32 -0500 | Rating Details | |
| 2024-03-31 08:52:47 -0500 | Rating Details | |
| 2024-03-31 08:50:26 -0500 | Rating Details | |
| 2024-03-31 08:15:56 -0500 | Rating Details | |
| 2024-03-31 07:58:22 -0500 | Rating Details | |
| 2024-03-31 06:50:01 -0500 | Rating Details | |
| 2024-03-31 06:35:54 -0500 | Rating Details | |
| 2024-03-31 06:18:59 -0500 | Rating Details | |
| 2024-03-31 05:36:28 -0500 | Rating Details | |
| 2024-03-31 05:06:10 -0500 | Rating Details | |
| 2024-03-31 04:26:13 -0500 | Rating Details | |
| 2024-03-31 04:21:01 -0500 | Rating Details | |
| 2024-03-31 04:04:50 -0500 | Rating Details | |
| 2024-03-31 03:37:19 -0500 | Rating Details | |
| 2024-03-31 02:15:13 -0500 | Rating Details | |
| 2024-03-31 02:09:44 -0500 | Rating Details | |
| 2024-03-31 01:50:01 -0500 | Rating Details | |
| 2024-03-31 01:13:29 -0500 | Rating Details | |
| 2024-03-31 00:48:47 -0500 | Rating Details | |
| 2024-03-31 00:46:14 -0500 | Rating Details | |
| 2024-03-31 00:39:44 -0500 | Rating Details | |
| 2024-03-31 00:38:42 -0500 | Rating Details | |
| 2024-03-31 00:32:45 -0500 | Rating Details | |
| 2024-03-31 00:31:56 -0500 | Rating Details | |
| 2024-03-31 00:29:38 -0500 | Rating Details | |
| 2024-03-31 00:29:22 -0500 | Rating Details | |
| 2024-03-31 00:22:04 -0500 | Rating Details | |
| 2024-03-31 00:14:51 -0500 | Rating Details | |
| 2024-03-31 00:13:21 -0500 | Rating Details | |
| 2024-03-31 00:11:39 -0500 | Rating Details | |
| 2024-03-31 00:10:52 -0500 | Rating Details | |
| 2024-03-31 00:09:04 -0500 | Rating Details | |
| 2024-03-31 00:08:26 -0500 | Rating Details | |
| 2024-03-31 00:04:42 -0500 | Rating Details | |
| 2024-03-31 00:01:49 -0500 | Rating Details | |
| 2024-03-31 00:01:32 -0500 | Rating Details | |
| 2024-03-31 00:00:32 -0500 | Rating Details | |
| 2024-03-30 23:59:57 -0500 | Rating Details | |
| 2024-03-30 23:53:52 -0500 | Rating Details | |
| 2024-03-30 23:53:00 -0500 | Rating Details | |
| 2024-03-30 23:43:04 -0500 | Rating Details | |
| 2024-03-30 23:37:43 -0500 | Rating Details | |
| 2024-04-01 18:05:04 -0500 | Rating Details | |
| 2024-04-01 17:43:55 -0500 | Rating Details | |
| 2024-04-01 16:53:29 -0500 | Rating Details | |
| 2024-03-31 19:20:21 -0500 | Rating Details | |
| 2024-03-31 18:29:46 -0500 | Rating Details | |
| 2024-03-31 15:40:05 -0500 | Rating Details | |
| 2024-03-31 15:21:30 -0500 | Rating Details | |
| 2024-03-31 14:01:00 -0500 | Rating Details | |
| 2024-03-31 13:34:34 -0500 | Rating Details | |
| 2024-03-31 11:40:22 -0500 | Rating Details | |
| 2024-03-31 10:52:31 -0500 | Rating Details | |
| 2024-03-31 10:21:50 -0500 | Rating Details | |
| 2024-03-31 08:50:00 -0500 | Rating Details | |
| 2024-03-31 08:33:10 -0500 | Rating Details | |
| 2024-03-31 07:49:20 -0500 | Rating Details | |
| 2024-03-31 07:26:41 -0500 | Rating Details | |
| 2024-03-31 06:13:46 -0500 | Rating Details | |
| 2024-03-31 05:47:11 -0500 | Rating Details | |
| 2024-03-31 05:46:10 -0500 | Rating Details | |
| 2024-03-31 05:22:25 -0500 | Rating Details | |
| 2024-03-31 04:28:09 -0500 | Rating Details | |
| 2024-03-31 04:25:28 -0500 | Rating Details | |
| 2024-03-31 04:19:41 -0500 | Rating Details | |
| 2024-03-31 03:53:44 -0500 | Rating Details | |
| 2024-03-31 03:31:06 -0500 | Rating Details | |
| 2024-03-31 03:20:14 -0500 | Rating Details | |
| 2024-03-31 03:10:23 -0500 | Rating Details | |
| 2024-03-31 03:00:18 -0500 | Rating Details | |
| 2024-03-31 02:42:53 -0500 | Rating Details | |
| 2024-03-31 02:16:35 -0500 | Rating Details | |
| 2024-03-31 01:49:01 -0500 | Rating Details | |
| 2024-03-31 01:43:22 -0500 | Rating Details | |
| 2024-03-31 01:22:39 -0500 | Rating Details | |
| 2024-03-31 01:06:40 -0500 | Rating Details | |
| 2024-03-31 00:57:34 -0500 | Rating Details | |
| 2024-03-31 00:54:24 -0500 | Rating Details | |
| 2024-03-31 00:45:43 -0500 | Rating Details | |
| 2024-03-31 00:43:01 -0500 | Rating Details | |
| 2024-03-31 00:42:56 -0500 | Rating Details | |
| 2024-03-31 00:39:15 -0500 | Rating Details | |
| 2024-03-31 00:21:10 -0500 | Rating Details | |
| 2024-03-31 00:16:21 -0500 | Rating Details | |
| 2024-03-31 00:11:35 -0500 | Rating Details | |
| 2024-03-31 00:04:22 -0500 | Rating Details | |
| 2024-03-31 00:00:48 -0500 | Rating Details | |
| 2024-03-30 23:59:13 -0500 | Rating Details | |
| 2024-03-30 23:57:59 -0500 | Rating Details | |
| 2024-03-30 23:55:31 -0500 | Rating Details | |
| 2024-03-30 23:54:47 -0500 | Rating Details | |
| 2024-03-30 23:54:15 -0500 | Rating Details | |
| 2024-03-30 23:54:01 -0500 | Rating Details | |
| 2024-03-30 23:52:06 -0500 | Rating Details | |
| 2024-03-30 23:47:30 -0500 | Rating Details | |
| 2024-03-30 23:42:08 -0500 | Rating Details | |
| 2024-03-30 23:38:10 -0500 | Rating Details | |
| 2024-03-30 23:37:55 -0500 | Rating Details | |
| 2024-04-08 12:39:58 -0500 | Rating Details | |
| 2024-03-31 08:08:33 -0500 | Rating Details | |
| 2024-04-15 20:46:57 -0500 | Rating Details | |
| 2024-04-07 09:52:27 -0500 | Rating Details | |
| 2024-04-06 12:25:18 -0500 | Rating Details | |
| 2024-04-04 18:23:45 -0500 | Rating Details | |
| 2024-04-02 22:07:37 -0500 | Rating Details | |
| 2024-04-01 19:51:47 -0500 | Rating Details | |
| 2024-04-01 18:58:16 -0500 | Rating Details | |
| 2024-04-01 18:47:54 -0500 | Rating Details | |
| 2024-04-01 17:16:28 -0500 | Rating Details | |
| 2024-03-31 22:14:27 -0500 | Rating Details | |
| 2024-03-31 12:54:55 -0500 | Rating Details | |
| 2024-03-31 08:59:57 -0500 | Rating Details | |
| 2024-04-01 18:04:45 -0500 | Rating Details | |
| 2024-04-25 19:24:52 -0500 | Rating Details | |
| 2024-04-27 20:13:31 -0500 | Rating Details | |
| 2024-05-04 09:00:51 -0500 | Rating Details | |
| 2024-05-16 07:06:29 -0500 | Rating Details | |
| 2024-05-16 04:12:56 -0500 | Rating Details | |
| 2024-10-25 20:18:48 -0500 | Rating Details | |
| 2024-12-18 19:46:42 -0600 | Rating Details |